- Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
Anthony Quagliano et al, 2020, Frontiers in Oncology CrossRef - Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
Yan Li et al, 2022, Clinical & Translational Immunology CrossRef - Modulating epigenetic modifications for cancer therapy (Review)
Leonardo Castro‑Muñoz et al, 2023, Oncology Reports CrossRef - The paradigm of drug resistance in cancer: an epigenetic perspective
Swagata Adhikari et al, 2022, Bioscience Reports CrossRef - Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma
Nemanja Djokovic et al, 2023, Pharmaceuticals CrossRef - Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state
Bo He et al, 2024, Cell Death & Disease CrossRef - Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications
Brittany Silverman et al, 2016, International Journal of Molecular Sciences CrossRef - Cancer Cell Fitness Is Dynamic
Luana S. Lenz et al, 2021, Cancer Research CrossRef - Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
Janaki Ramaiah Mekala et al, 2018, Gene CrossRef - Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach
Kasturi Ranganna et al, 2020, International Journal of Molecular Sciences CrossRef - Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
Xue-Song Xiang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef - Methods for Hydroxamic Acid Synthesis
Mohammad A. Alam, 2019, Current Organic Chemistry CrossRef - DNA and Histone Methylation in Liver Cancer
Eri Arai et al, 2017, DNA and Histone Methylation as Cancer Targets CrossRef